PCM
AGN.PRA

Palisade Capital Management’s Allergan plc AGN.PRA Stock Holding History

Palisade Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,502
Closed -$17.9M – 590
2016
Q2 		$17.9M Buy
21,502
+1,174
+6% +$981K 0.65% 32
2016
Q1 		$18.6M Buy
20,328
+1,024
+5% +$979K 0.61% 32
2015
Q4 		$19.8M Sell
19,304
-4,591
-19% -$4.61M 0.64% 29
2015
Q3 		$22.6M Buy
23,895
+1,166
+5% +$1.22M 0.67% 22
2015
Q2 		$23.7M Buy
+22,729
New +$23.8M 0.6% 26

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Palisade Capital Management's AGN.PRA Position: Q3 2016 in Review

Palisade Capital Management sold out of Allergan plc (AGN.PRA) in Q3 2016, closing a stake of 21,502 shares — an estimated $17.9M sold.

Palisade Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 5 quarters. The position peaked at $23.7M in Q2 2015. 117 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2016.

  • Palisade Capital Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Palisade Capital Management sold 21,502 Allergan plc shares in Q3 2016, an estimated $17.9M.
  • Palisade Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Palisade Capital Management's Allergan plc position peaked at $23.7M in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Palisade Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.